Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.735
+0.0101.38%
Volume:637.55K
Turnover:474.41K
Market Cap:350.64M
PE:-95.22
High:0.755
Open:0.730
Low:0.725
Close:0.725
52wk High:0.815
52wk Low:0.107
Shares:477.05M
Float Shares:347.84M
Volume Ratio:0.44
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.008
EPS(LYR):-0.024
ROE:-14.47%
ROA:-7.24%
PB:16.32
PE(LYR):-30.69

Loading ...

Company Profile

Company Name:
STARPHARMA HOLDINGS LTD
Exchange:
ASX
Establishment Date:
1997
Employees:
40
Office Location:
4-6 Southampton Crescent,Abbotsford,Victoria,Australia
Zip Code:
3067
Fax:
61 3 9510 5955
Introduction:
Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.